{"id":"https://openalex.org/W2286301863","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","title":"Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer","display_name":"Phase I trial involving the pharmacodynamic (PD) study of circulating tumour cells, of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), with docetaxel (D) in patients (p) with advanced cancer","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2286301863","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","mag":"2286301863"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.3023","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Attard","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056423529","display_name":"Peter C.C. Fong","orcid":"https://orcid.org/0000-0003-2689-8958","observed_orcids":["https://orcid.org/0000-0003-2689-8958"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. C. Fong","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081461713","display_name":"R. Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Molife","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014614759","display_name":"Sarah Reade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Reade","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103032196","display_name":"Heather May Shaw","orcid":"https://orcid.org/0000-0002-6545-2927","observed_orcids":["https://orcid.org/0000-0002-6545-2927","https://orcid.org/0009-0005-1092-0278"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Shaw","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113271812","display_name":"A. Reid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Reid","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491","https://orcid.org/0009-0005-6890-2128"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Spicer","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110348031","display_name":"Julia Hamlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Hamlin","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021891844","display_name":"Antonio Gualberto","orcid":"https://orcid.org/0000-0002-6590-839X","observed_orcids":["https://orcid.org/0000-0002-6590-839X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Gualberto","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. S. De Bono","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust, London, United Kingdom; Pfizer Ltd, Sandwich, Kent, United Kingdom; Pfizer Ltd, Groton, CT","institution_ids":["https://openalex.org/I1325846038"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1325846038"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"3023","last_page":"3023"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9272000193595886,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9850000143051147},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9440000057220459},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8050000071525574},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6019999980926514},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7670000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6710000038146973},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7649999856948853},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6980000138282776},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8959062099456787},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7634494304656982},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7275142073631287},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7088866829872131},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.615323543548584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5251379013061523},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.48924756050109863},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4768725037574768},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4571087956428528},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.44108328223228455},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.40906772017478943},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3305049538612366},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3131130635738373},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.18603861331939697}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.3023","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.3023","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049684251","https://openalex.org/W2207381344","https://openalex.org/W2112474467","https://openalex.org/W2040104879","https://openalex.org/W2765414112","https://openalex.org/W2340451576","https://openalex.org/W2121520362","https://openalex.org/W2246578212","https://openalex.org/W2419131614","https://openalex.org/W2088913927"],"abstract_inverted_index":{"3023":[0],"Background:":[1],"C":[2,44,65,95,111,129,140,197,256,294,312],"is":[3,303],"the":[4,29,122,144],"first":[5],"specific,":[6],"fully":[7],"human,":[8],"monoclonal":[9],"antibody":[10],"to":[11,139,141,149,274,311],"target":[12],"IGF-1R":[13,20,55,280,288],"in":[14,78,161,169,264,276,284,317],"clinical":[15],"trials.":[16],"It":[17],"potently":[18],"inhibits":[19],"signaling,":[21],"enhancing":[22],"D":[23,41,84,99],"antitumour":[24],"activity.":[25],"This":[26,301],"trial":[27],"investigated":[28],"safety,":[30],"feasibility,":[31],"dose":[32],"limiting":[33],"toxicity":[34,135,309],"(DLT),":[35],"PK":[36],"and":[37,57,61,75,158,234,305,313],"antitumor":[38,315],"activity":[39,316],"of":[40,81,110,121,128,245,266,278],"administered":[42],"with":[43,112,143,177,230,255,293,307],"every":[45],"3":[46,165,170,298],"weeks.":[47],"PD":[48],"studies":[49],"evaluated":[50],"circulating":[51],"tumor":[52],"cell":[53],"(CTC)":[54],"expression":[56,281],"CTC":[58,261,287],"counts":[59],"pre-":[60],"post-treatment.":[62],"Methods:":[63],"The":[64],"doses":[66,296],"tested":[67],"were":[68,154,262],"0.1,":[69],"0.4,":[70],"0.8,":[71],"1.5,":[72],"3.0,":[73],"6.0":[74],"10":[76],"mg/kg":[77],"sequential":[79],"cohorts":[80],"3\u20136":[82],"p.":[83,163,286],"was":[85,167,174,183,282,289],"fixed":[86],"at":[87,295],"75mg/m2.":[88],"P":[89],"achieving":[90],"disease":[91,237],"control":[92],"continued":[93],"on":[94,186],"alone":[96,130,257],"if":[97],"experiencing":[98],"toxicity.":[100,214],"Results:":[101],"21":[102,126],"p":[103,115,222,251,268],"(20":[104],"male)":[105],"have":[106,131,225,252],"received":[107,116],"100":[108],"courses":[109,120,127],"D.":[113,150],"7":[114],"8":[117],"or":[118],"more":[119],"combination.":[123],"A":[124],"further":[125],"been":[132,137,201,207],"administered.":[133],"No":[134],"has":[136,200,205],"attributed":[138,310],"date":[142],"observed":[145],"toxicities":[146,153],"being":[147],"attributable":[148],"Grade":[151,164],"3/4":[152],"neutropenia":[155],"(16/21":[156],"p)":[157],"neutropenic":[159],"fever":[160],"2/21":[162],"diarrhea":[166],"reported":[168],"p,":[171],"but":[172,194],"this":[173],"easily":[175],"controlled":[176],"antidiarrheals.":[178],"Transient":[179],"grade":[180],"1":[181,273],"hyperglycaemia":[182],"noted":[184],"largely":[185],"day":[187],"1,":[188],"following":[189,291],"steroid":[190],"premedication":[191],"(14":[192],"p),":[193],"no":[195,212,308],"significant":[196],"related":[198],"hyperglycemia":[199],"observed.":[202],"An":[203],"MTD":[204],"not":[206],"reached.":[208],"Serial":[209],"echocardiograms":[210],"demonstrated":[211],"cardiac":[213],"Of":[215],"18":[216,267],"castration":[217],"resistant":[218],"prostate":[219],"cancer":[220],"(CRPC)":[221],"treated,":[223],"4":[224],"had":[226],"a":[227],"confirmed":[228],"PR,":[229],"2":[231,235],"unconfirmed":[232],"PR":[233],"having":[236],"stabilization":[238],"for":[239,258],">":[240],"6":[241],"months":[242],"(median":[243],"number":[244],"courses:":[246],"10;":[247],"range:":[248],"3\u201312).":[249],"5":[250],"maintained":[253],"SD":[254],"2\u20137":[259],"courses.":[260],"detected":[263,283],"16":[265],"(CTC":[269],"numbers":[270],"ranged":[271],"from":[272],"202":[275],"7.5ml":[277],"blood).":[279],"12":[285],"undetectable":[290],"treatment":[292],"above":[297],"mg/kg.":[299],"Conclusions:":[300],"combination":[302],"safe":[304],"feasible":[306],"encouraging":[314],"CRPC.":[318],"[Table:":[319],"see":[320],"text]":[321]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}